FindTrial
Sign In

Effect of drug therapy on pregnancy outcome of subclinical intrauterine infection in pregnant women with preterm unbroken membranes

Effect of drug therapy on pregnancy outcome of subclinical intrauterine infection in pregnant women with preterm unbroken membranes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073077
Enrollment
Unknown
Registered
2023-06-30
Start date
2023-07-01
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subclinical intrauterine infection

Interventions

Observation group:N/A

Sponsors

Sun Yat-Sen Memorial Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Preterm pregnant women with intact membranes between 14 and 36+6 weeks of gestation; Pregnant women who consent to amniocentesis for amniotic fluid testing; Subclinical intrauterine infection occurred before drug intervention during pregnancy; Delivery in our hospital; The newborn was discharged from our hospital.

Exclusion criteria

Exclusion criteria: Pregnant women with preterm rupture of membranes before drug intervention; Genital structural abnormalities (except cervical insufficiency); There are clear clinical indications of infection.

Design outcomes

Primary

MeasureTime frame
Index of infection;Medication situation;—

Countries

China

Contacts

Public ContactJiaxin Zhang

Sun Yat-Sen Memorial Hospital

766793012@qq.com+86 159 1578 9418

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026